Annual Immunisation Coverage Report 2017.
Adolescent
Algorithms
Annual Reports as Topic
Australia
/ epidemiology
Child, Preschool
Cohort Studies
Female
Health Services, Indigenous
Humans
Immunization
Immunization Programs
Infant
Male
Native Hawaiian or Other Pacific Islander
/ statistics & numerical data
Papillomaviridae
/ immunology
Papillomavirus Infections
/ prevention & control
Papillomavirus Vaccines
/ administration & dosage
Registries
Vaccination Coverage
Indigenous immunisation coverage
adolescent immunisation coverage
human papillomavirus vaccine coverage
immunisation coverage
immunisation delay
influenza vaccination
Journal
Communicable diseases intelligence (2018)
ISSN: 2209-6051
Titre abrégé: Commun Dis Intell (2018)
Pays: Australia
ID NLM: 101735394
Informations de publication
Date de publication:
18 Nov 2019
18 Nov 2019
Historique:
entrez:
19
11
2019
pubmed:
19
11
2019
medline:
27
11
2019
Statut:
epublish
Résumé
This eleventh national annual immunisation coverage report focuses on data for the calendar year 2017 derived from the Australian Immunisation Register (AIR) and the National Human Papillomavirus (HPV) Vaccination Program Register. This is the first report to include data on HPV vaccine course completion in Aboriginal and Torres Strait Islander (Indigenous) adolescents. 'Fully immunised' vaccination coverage in 2017 increased at the 12-month assessment age reaching 93.8% in December 2017, and at the 60-month assessment age reaching 94.5%. 'Fully immunised' coverage at the 24-month assessment age decreased slightly to 89.8% in December 2017, following amendment in December 2016 to require the fourth DTPa vaccine dose at 18 months. 'Fully immunised' coverage at 12 and 60 months of age in Indigenous children reached the highest ever recorded levels of 93.2% and 96.9% in December 2017. Catch-up vaccination activity for the second dose of measles-mumps-rubella-containing vaccine was considerably higher in 2017 for Indigenous compared to non-Indigenous adolescents aged 10-19 years (20.3% vs. 6.4%, respectively, of those who had not previously received that dose). In 2017, 80.2% of females and 75.9% of males aged 15 years had received a full course of three doses of human papillomavirus (HPV) vaccine. Of those who received dose one, 79% and 77% respectively of Indigenous girls and boys aged 15 years in 2017 completed three doses, compared to 91% and 90% of non-Indigenous girls and boys, respectively. A separate future report is planned to present adult AIR data and to assess completeness of reporting.
Identifiants
pubmed: 31738865
doi: 10.33321/cdi.2019.43.47
doi:
Substances chimiques
Papillomavirus Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© Commonwealth of Australia CC BY-NC-ND.